| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.008 |